Loading news...
Swapping 0% APR notes for 7% APR notes just to get three extra years before debt maturity is not a good look for a company that regularly loses money. Beyond Meat's sales are declining across the board as the plant-based meat industry continues to fade.
Automotive Properties Real Estate Investment Trust ( APR.UN:CA ) Q3 2025 Earnings Call November 14, 2025 9:00 AM EST Company Participants Milton Lamb - President, CEO & Director Andrew Kalra - CFO & Corporate Secretary Conference Call Participants Jonathan Kelcher - TD Cowen, Research Division J. Chen Zemin Liu - Desjardins Securities Inc., Research Division Giuliano Thornhill - National Bank Financial, Inc., Research Division Sairam Srinivas - Cormark Securities Inc., Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Automotive Properties REIT's 2025 Third Quarter Results Conference Call and Webcast.
This article has been disseminated on behalf of ESGold Corp . and may include a paid advertisement.
This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.
AUSTIN, Texas, Oct. 31, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) title “Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology,” featuring Oncotelic Therapeutics Inc. (OTCQB: OTLC).
AUSTIN, Texas, Oct. 27, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” featuring Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF). To hear the NetworkNewsAudio version, visit https://nnw.fm/m5BU6 To read the original editorial, visit https://nnw.fm/7yoEs This integration of AI with volumetric imaging technologies, such as tomosynthesis, MRI and dedicated breast CT, signals a broader shift toward intelligent diagnostics capable of generating and interpreting 3D data simultaneously.
DOYLESTOWN, Pa., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while minimizing damage to healthy cells, today provided an update on the ongoing Phase 1 ACESOT-1051 (A Multi-Center Evaluation of WEE1 Inhibitor in Patients with Advanced Solid Tumors, APR-1051) study. The latest results show that, at the 100 mg APR-1051 dose level, 3 out of 4 patients achieved stable disease, as measured using RECIST v1.1 criteria.
AUSTIN, Texas, Oct. 24, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Gold Surges Past $4,200 as Investors Flock to Producers with Cash Flow,”featuring ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF).
AUSTIN, Texas, Oct. 10, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “When the Dollar Blinks, Real Assets Take Center Stage,” featuring ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF).
AUSTIN, Texas, Sept. 29, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Record Gold Prices Create Unprecedented Opportunities for Near-Term Producers,” featuring LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF).